Philip Newland-JonesClinician
consultant pharmacist in diabetes and endocrinology at the University of Southampton
Cited in UK press coverage of health & social care
1 citation
Across 1 topic, first on 27 Aug 2026.
Expertise
Cited on
What they’ve said
“The introduction, initiation and titration of once-weekly insulin represents a significant change in diabetes care for specialists and other insulin prescribers. National guidance, alongside practical multidisciplinary consensus recommendations, will be needed to support the safe, effective and consistent use of these therapies across clinical settings.”
consultant pharmacist in diabetes and endocrinology at the University of Southampton · Diabetes · 27 Aug 2026 · Once-weekly insulin would be ‘significant change’ for diabetes prescribers ↗
Source references
- Once-weekly insulin would be ‘significant change’ for diabetes prescriberspharmaceutical-journal.com · 27 Aug 2026
Doctors, nurses, allied health professionals and other registered clinicians quoted in a clinical capacity. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.